PETACH TIKVA, Israel, March 21, 2017 OWC Pharmaceutical Research Corp Releases Promising Preliminary Results From Efficacy Tests of its Topical Cream Read More

PETACH TIKVA, Israel, February 27, 2017 OWC Pharmaceutical Research Corp Receives IRB Approval to Initiate Safety Testing on its Cannabinoid-Infused Cream for Treatment of Psoriasis  Read More

PETACH TIKVA, Israel, February 17, 2017 OWC Pharmaceutical Research to Present at Lyons Capital’s Wall Street Conference  Read More

PETACH TIKVA, Israel, February 7, 2017 OWC Pharmaceutical Research Corp Appoints Dr. Sharon Rozenblat Senior Advisor to Scientific Advisory Board of its Wholly-Owned Subsidiary  Read More

PETACH TIKVA, Israel, January 27, 2017 OWC Pharmaceutical Research Corp Announces the Nominations of Ms. Miriam Sani, MSc Eng., to its Advisory Board  Read More

PETACH TIKVA, Israel, January 17, 2017  — OWC Pharmaceutical Research Corp Issues Annual Letter to Shareholders Read More

SEATTLE, WA, USA, January 4, 2017 – CFN Media Exclusive Interview with Jeffrey Friedland, Advisory Board Member for OWC Pharmaceutical Research Corp Read More

2016

PETACH TIKVA, Israel, November 18, 2016  — OWC Pharmaceutical Corp Advisory Board Member to Participate in the First Bloomberg Intelligence Sponsored Cannabis Event. Bloomberg’s “Cannabis Trends & Legalization Implications” Will be Held Monday, November 21st in New York. Read More

PETACH TIKVA, Israel, November 15, 2016  — OWC Pharmaceutical Corp to Submit Psoriasis Topical Cream IRB Safety Protocol to the Israeli National IRB (“Helsinki”) Committee. Final IRB (“Institutional Review Board”) for safety study. Read More

PETACH TIKVA, Israel, November 7, 2016  — OWC Pharmaceutical Corporation Advisory Board Member, Jeffrey Friedland, Comments on the Election and the Possible Impact on the U.S. Cannabis Market. What could be the impact of tomorrow’s US elections on Cannabis? Read More

PETACH TIKVA, Israel, November 3, 2016  — OWC Pharmaceutical Research Corp Signs Investment and Joint Venture with Michepro Holdings Ltd. Read More

PETACH TIKVA, Israel, October 20, 2016  — OWC Pharmaceutical Research Corp Completes Development of Its Medical Cannabis Sublingual Tablet. The proprietary delivery mechanism provides smoke-free alternative for patients using medical cannabis. Read More

PETACH TIKVA, Israel, October 11, 2016  — OWC Pharmaceutical Research Corp to Initiate Efficacy Testing on its Cannabinoid-Infused Cream for Treatment of Psoriasis. The Company’s recently completed Challenge Testing for the topical crème, successfully demonstrated the product’s robustness against microbiological contamination, stability, and provided a preliminary safety assessment. Read More

PETACH TIKVA, Israel, September 30, 2016  — OWC Pharmaceutical Research Corp Signs Agreement With US Partner for Funding in Advance of Future Royalties. Mr. Weinstein, CEO of Medmar, said “We learned about OWC as they are one of only a handful of companies taking a true clinical approach to the research and development of medical cannabis.” Read More

PETACH TIKVA, Israel, April 26, 2016  — OWC Pharmaceutical Research Corp to Present at Israeli Advanced Technology Industry’s BioMed Conference. The Conference is a part of Israel’s 15th National Life Sciences and Technology Week, and is being held May 24th to 26th at the David Intercontinental Hotel in Tel Aviv, Israel. The Company is currently scheduled to present at Booth #80 on the 24th. Read More

PETACH TIKVA, Israel, April 12, 2016  — OWC Pharmaceutical Research Comments on Israel’s Proposed Medical Cannabis Guidelines Read More

PETACH TIKVA, Israel, March 29, 2016  — OWC Pharmaceutical Research Advances Its Multiple Myeloma Study to Animals Read More

PETACH TIKVA, Israel, March 15, 2016  — OWC Pharmaceutical Research Announces the Nomination of Mr. Jeffrey Friedland Joins OWC Pharmaceutical Research’s Advisory Board Read More

PETACH TIKVA, Israel, March 9, 2016  — OWC Pharmaceutical Research Corp Completes Formulation of Cannabinoid-Infused Topical Cream Read More

PETACH TIKVA, Israel, Feb 16, 2016  — OWC Pharmaceutical Research Corp. Issues Letter to Shareholders Read More

PETACH TIKVA, Israel, January 11, 2016  — OWC Pharmaceutical Research Announces $750K Equity Purchase Agreement With Kodiak Capital Group Read More

2015

PETACH TIKVA, Israel, July 15, 2015  — One World Cannabis to Offer New Alternative Treatment for Chronic Pain in Light Of FDA’s NSAIDs Warning  Read More

PETACH TIKVA, Israel, June 17, 2015  — OWC Pharmaceutical Research Announces the Promising Results of Phase Lab Testing for Multiple Myeloma  Read More Hebrew

PETACH TIKVA, Israel, May 18, 2015  — One World Cannabis Implements Regulatory – Patient-Care Services for New York Applications in Medical Cannabis Program  Read More

PETACH TIKVA, Israel, May 13, 2015  — OWC Pharmaceutical Research and Sheba Medical Center to Extend Contract for Fibromyalgia Clinical Trials  Read More

PETACH TIKVA, Israel, April 22, 2015 – OWC Partners With G.C. Group to Develop Cannabinoid-Based Formulations and Delivery Methods for Several Medical Indications  Read More

PETACH TIKVA, Israel, April 15, 2015 – One World Cannabis Moves Forward to Test Human Cells in its Multiple Myeloma Study  Read More

PETACH TIKVA, Israel, March 24, 2015 – One World Cannabis Files 6th Provisional Patent Application With USPTO  Read More

PETACH TIKVA, Israel, March 19, 2015 – One World Cannabis to Present at the Wall St. Conference in Miami on March 23rd  Read More

PETACH TIKVA, Israel, March 11, 2015 – One World Cannabis Signed a Collaboration Agreement with Sheba Academic Medical Center  Read More

PETACH TIKVA, Israel, March 5, 2015 – One World Cannabis to Present at Prague Medical Cannabis Conference  Read More